Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Heart

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 3 · 100%

All causes of mortality at 30 days · Anticoagulants in ACS

Factor Xa inhibitors showed no clear difference in all causes of mortality at 30 days compared with anticoagulants (high certainty).

1 finding from 1 review

Factor Xa inhibitors for acute coronary syndromes 2011 · Cochrane Headline outcomes only
RR 0.9 [0.8, 1.01]
4 studies · 27976 participants
High

All causes of mortality at 30 days ‐ UFH · Anticoagulants in ACS

Factor Xa inhibitors showed no clear difference in all causes of mortality at 30 days ‐ UFH compared with anticoagulants (high certainty).

1 finding from 1 review

Factor Xa inhibitors for acute coronary syndromes 2011 · Cochrane Headline outcomes only
RR 0.98 [0.82, 1.18]
2 studies · 6760 participants
High

All causes of mortality at 30 days ‐ Enoxaparin · Anticoagulants in ACS

Factor Xa inhibitors leads to lower all causes of mortality at 30 days ‐ Enoxaparin compared with anticoagulants (high certainty).

1 finding from 1 review

Factor Xa inhibitors for acute coronary syndromes 2011 · Cochrane Headline outcomes only
RR 0.85 [0.73, 0.98]
2 studies · 21216 participants
High